


New Options for Treatment-Resistant RA

Filgotinib Promising for RA

FDA Approves Rituximab Biosimilar; Plus New Safety Data for Filgotinib in RA Patients

Zilretta Promising for Blood Glucose Levels; Plus Filgotinib Promising for RA

• By Carina Stanton
The Foundation is the largest private funding source for rheumatology research and training in the U.S.
Visit the official website for the American College of Rheumatology.
Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.